Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;89(11):1420-2.
doi: 10.1136/bjo.2005.073817.

Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review

S Sivaprasad  1 , C Bunce, R Wormald
Affiliations

Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review

S Sivaprasad et al. Br J Ophthalmol. 2005 Nov.

Abstract

Aim: To examine the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of cystoid macular oedema (CMO) following cataract surgery.

Methods: Systematic literature review of randomised controlled trials (RCTs) that evaluated the effects of NSAIDs in the treatment of CMO following cataract surgery was done according to the Cochrane Collaboration methodology.

Results: Seven trials involving a total of 266 participants were included. Four trials studied the effects of NSAIDs in chronic CMO while the other three trials examined the effect of NSAIDs in acute CMO. Little evidence of effectiveness was found for oral indomethacin and topical fenoprofen for chronic CMO in two small trials. Treatment with topical 0.5% ketorolac for chronic CMO was found to be effective in two trials. Three trials examined the effect of topical NSAIDs on acute CMO. The comparisons among these studies were of a NSAID to placebo, prednisolone or another NSAID. Because of considerable heterogeneity between these study designs, their results were not combined in a meta-analysis.

Conclusion: A positive effect of topical NSAID (0.5% ketorolac tromethamine ophthalmic solution) on chronic CMO was noted. However, there is not enough evidence to show the effectiveness of NSAIDs in acute CMO following cataract surgery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Improvement of vision at end of treatment.
Figure 2
Figure 2
Improvement of vision 1 month after treatment.
See this image and copyright information in PMC

References

    1. Drolsum L, Haaskjold E. Causes of decreased visual acuity after cataract extraction. J Cataract Refract Surg 1995;21:59–63. - PubMed
    1. Rossetti L, Chaudhuri J, Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 1998;105:397–405. - PubMed
    1. Sivaprasad S, Bunce C, Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD 004239. DOI:10.1002/14651858.CD004239.pub2. - PubMed
    1. Alderson P, Green S, Higgins JPT, eds. Cochrane reviewers’ handbook 4.2.2 In: The Cochrane Library, Issue 1, 2004. Chichester: John Wiley & Sons, Ltd (updated March 2004).
    1. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557–634. - PMC - PubMed

Publication types

MeSH terms

Substances